Published in Cell Mol Bioeng on September 01, 2013
Biophysical regulation of Chlamydia pneumoniae-infected monocyte recruitment to atherosclerotic foci. Sci Rep (2016) 0.79
Shear stress upregulates IL-1β secretion by Chlamydia pneumoniae- infected monocytes. Biotechnol Bioeng (2015) 0.78
Biophysical and Biochemical Outcomes of Chlamydia pneumoniae Infection Promotes Pro-atherogenic Matrix Microenvironment. Front Microbiol (2016) 0.75
Antibiotic treatment of Chlamydia pneumoniae after acute coronary syndrome. N Engl J Med (2005) 4.13
Monocyte chemoattractant protein-1 in human atheromatous plaques. J Clin Invest (1991) 3.82
Combined inhibition of CCL2, CX3CR1, and CCR5 abrogates Ly6C(hi) and Ly6C(lo) monocytosis and almost abolishes atherosclerosis in hypercholesterolemic mice. Circulation (2008) 3.69
Elevated Chlamydia pneumoniae antibodies, cardiovascular events, and azithromycin in male survivors of myocardial infarction. Circulation (1997) 2.95
Replication of Chlamydia pneumoniae in vitro in human macrophages, endothelial cells, and aortic artery smooth muscle cells. Infect Immun (1996) 2.52
Chlamydia pneumoniae--an infectious risk factor for atherosclerosis? Nat Rev Microbiol (2004) 2.34
Chlamydia pneumoniae (TWAR) in atherosclerosis of the carotid artery. Circulation (1995) 2.24
Chlamydia pneumoniae (TWAR) in coronary arteries of young adults (15-34 years old). Proc Natl Acad Sci U S A (1995) 2.15
Antagonism of RANTES receptors reduces atherosclerotic plaque formation in mice. Circ Res (2003) 1.99
Chemokine CXCL10 promotes atherogenesis by modulating the local balance of effector and regulatory T cells. Circulation (2006) 1.95
Evidence of systemic dissemination of Chlamydia pneumoniae via macrophages in the mouse. J Infect Dis (1998) 1.89
Up-regulated expression of the CXCR2 ligand KC/GRO-alpha in atherosclerotic lesions plays a central role in macrophage accumulation and lesion progression. Am J Pathol (2006) 1.67
The specific role of chemokines in atherosclerosis. Thromb Haemost (2007) 1.62
The use of THP-1 cells as a model for mimicking the function and regulation of monocytes and macrophages in the vasculature. Atherosclerosis (2011) 1.62
Role for ADAP in shear flow-induced platelet mechanotransduction. Blood (2009) 1.55
Elevated monocyte chemoattractant protein-1 serum levels in patients at risk for coronary artery disease. Circ J (2005) 1.31
Chlamydophila pneumoniae and the etiology of late-onset Alzheimer's disease. J Alzheimers Dis (2008) 1.21
Growth of Chlamydia pneumoniae induces cytokine production and expression of CD14 in a human monocytic cell line. Infect Immun (1996) 1.17
Confirmed previous infection with Chlamydia pneumoniae (TWAR) and its presence in early coronary atherosclerosis. Circulation (1998) 1.15
Phagocytes transmit Chlamydia pneumoniae from the lungs to the vasculature. Eur Respir J (2004) 1.06
Acellular components of Chlamydia pneumoniae stimulate cytokine production in human blood mononuclear cells. Eur J Immunol (2000) 1.05
Chlamydia pneumoniae: modern insights into an ancient pathogen. Trends Microbiol (2012) 1.03
Chlamydia pneumoniae induces inflammatory changes in the heart and aorta of normocholesterolemic C57BL/6J mice. Infect Immun (2000) 1.01
Demonstration of viable Chlamydia pneumoniae in atherosclerotic plaques of carotid arteries by reverse transcriptase polymerase chain reaction. Ann Vasc Surg (1999) 0.99
Infection of U937 monocytic cells with Chlamydia pneumoniae induces extensive changes in host cell gene expression. J Infect Dis (2003) 0.99
Effect of azithromycin on murine arteriosclerosis exacerbated by Chlamydia pneumoniae. J Infect Dis (2000) 0.97
Expression and cellular localization of the CC chemokines PARC and ELC in human atherosclerotic plaques. Am J Pathol (1999) 0.94
Chlamydia pneumoniae infection promotes the transmigration of monocytes through human brain endothelial cells. J Neurosci Res (2003) 0.93
Infection, antibiotics, and atherothrombosis--end of the road or new beginnings? N Engl J Med (2005) 0.93
Chemokines, leukocytes, and atherosclerosis. J Lab Clin Med (2000) 0.92
Endothelial mechanosensors of shear stress as regulators of atherogenesis. Curr Opin Lipidol (2012) 0.92
Chlamydophila pneumoniae. Mechanisms of target cell infection and activation. Thromb Haemost (2005) 0.91
Shear-induced resistance to neutrophil activation via the formyl peptide receptor. Biophys J (2012) 0.91
Chlamydia pneumoniae-infected monocytes exhibit increased adherence to human aortic endothelial cells. Microbes Infect (2001) 0.89
Chlamydia pneumoniae infection induces differentiation of monocytes into macrophages. Infect Immun (2002) 0.88
Differential expression patterns of proinflammatory and antiinflammatory mediators during atherogenesis in mice. Arterioscler Thromb Vasc Biol (2004) 0.88
An Integrative Review of Mechanotransduction in Endothelial, Epithelial (Renal) and Dendritic Cells (Osteocytes). Cell Mol Bioeng (2011) 0.87
Cultivation and laboratory maintenance of Chlamydia pneumoniae. Curr Protoc Microbiol (2009) 0.86
Transmission of Chlamydia pneumoniae infection from blood monocytes to vascular cells in a novel transendothelial migration model. FEMS Microbiol Lett (2005) 0.85
Reactive oxygen species generation in peripheral blood monocytes and oxidized LDL are increased in hyperlipidemic patients. Clin Biochem (2009) 0.85
Chlamydia pneumoniae induces aponecrosis in human aortic smooth muscle cells. BMC Microbiol (2005) 0.83
Differential effects of Chlamydia pneumoniae infection on cytokine levels in human T lymphocyte- and monocyte-derived cell cultures. Int J Med Microbiol (2007) 0.83
Mechanisms for cell activation and its consequences for biorheology and microcirculation: Multi-organ failure in shock. Biorheology (2001) 0.82
Chlamydia-induced reactive arthritis: hidden in plain sight? Best Pract Res Clin Rheumatol (2011) 0.82
Chlamydia, inflammation, and atherogenesis. J Infect Dis (2000) 0.81
Hydrodynamic regulation of monocyte inflammatory response to an intracellular pathogen. PLoS One (2011) 0.79
Susceptibility of human monocyte-macrophages to Chlamydia pneumoniae infection in vitro is highly variable and associated with levels of soluble CD14 and C. pneumoniae IgA and human HSP-IgG antibodies in serum. Scand J Immunol (2008) 0.79
Systemic inflammation, Chlamydia pneumoniae DNA in circulating leukocytes and coronary atherosclerosis. Acta Cardiol (2002) 0.78
The role of infection and immunity in atherosclerosis. Expert Rev Cardiovasc Ther (2006) 0.77
Chemokines: the link between inflammation, restenosis and atherosclerosis? Int J Cardiol (2001) 0.76